CellMosaic is a private biotech company focusing on the development of bioconjugation reagents and platform technologies for drug development, biodetection, and basic research. CellMosaic was established in 2008 by a group of scientists who have extensive experience in the bioconjugation field and have published numerous patents and papers on protein, antibody, peptide, and oligonucleotide-based bioconjugation. Over the last two years, CellMosaic has spent a lot of research effort on developing new crosslinking chemistries, a small molecule and biologic drug conjugation/delivery platform, and single or site-specific labeling methods for biopolymers. We recently filed a patent application for new crosslinking reagents and developed our proprietary AqueaTether™ technology platform for drug bioconjugation and delivery.

CellMosaic helps pharmaceutical and biotech companies develop innovative bioconjugate-based therapies. We offer bioconjugate drug development through either the classical approach or our proprietary AqueaTether™ technologies. To explore the potential collaboration opportunities for developing new biopolymer-small drug conjugates, AqueaTether™ biologics, and small molecule drug delivery system based on our proprietary technologies, please contact us for details.

In light of the need for more information-based medicine in healthcare, CellMosaic strives to help diagnostic companies develop more specific and sensitive diagnostic reagents based on oligos, proteins, antibodies, peptides, and enzymes. We offer the diagnostic reagent development through either the classical approach or using our propriety AqueaTether™ technologies. To explore the potential collaboration opportunities for developing new diagnostic bioconjugates based on AqueaTether™, please contact us for details.

CellMosaic also facilitates biological research by offering a wide range of crosslinking reagents, ready-to-go kits, bioconjugates, and custom bioconjugation. For special chemicals, reagents, bioconjugates, and custom bioconjugation, please visit our products & services site.